AbbVie Inc. is 212.9x more valuable than Bausch Health Companies Inc. by market capitalization ($402.35 B vs $1.89 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHC | ABBV |
|---|---|---|
| Market cap | $1.89 B | $402.35 B |
| US-listed rank | #2149 | #31 |
| Revenue (latest FY) | $10.27B | $61.16B |
| Net income (latest FY) | $157.00M | $4.23B |
| Net margin | 1.5% | 6.9% |
| P/E (trailing FY) | 12.0 | 95.2 |
| SEC filings | 2,398 | 1,008 |
AbbVie Inc. is 212.9x more valuable than Bausch Health Companies Inc. by market capitalization ($402.35 B vs $1.89 B).
In their latest fiscal years, Bausch Health Companies Inc. reported $10.27B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Bausch Health Companies Inc. and AbbVie Inc., or browse the full rankings.